Status Topic selection
Technology type Medicine
Decision Not selected
Reason for decision Not eligible for Health Technology Evaluation guidance
Further information Following confirmation from NHS England that the existing policy available for glucarpidase will be reviewed and updated once marketing authorisation (MA) is received, decision makers have concluded that this technology will not progress as a potential technology appraisal or a highly specialised technology.
ID number 10761

Project Team

Project lead Danielle Lees

Email enquiries


Key events during the development of the guidance:

Date Update
09 December 2022 Topic selection. Status changed to allow selection decision to be updated
02 September 2022 Awaiting development. Status change linked to Topic Selection Decision being set to Selected

For further information on how we select topics for development, please see our page about topic selection